ALPHA TEKNOVA, INC. Total Liabilities
ALPHA TEKNOVA, INC. (TKNO) had Total Liabilities of $33.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $33.28M.
- 2026-03-31: Liabilities $33.73M.
- 2025-12-31: Liabilities $34.81M.
- 2025-09-30: Liabilities $34.98M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $33.28M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $33.73M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $34.81M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $34.98M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $34.43M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $35.39M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $36.38M 10-K · filed 2026-03-02 |
| 2024-09-30 | $36.83M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $36.42M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $37.44M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $38.55M 10-K · filed 2025-03-07 |
| 2023-09-30 | $38.73M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $46.34M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $48.93M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $52.38M 10-K · filed 2024-03-27 |
| 2022-09-30 | $48.28M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $48.73M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $45.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $23.31M 10-K · filed 2023-03-30 |
| 2021-09-30 | $22.94M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.53M 10-Q · filed 2021-08-13 |
| 2020-12-31 | $10.51M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |